C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?

被引:3
|
作者
Sellier, C. [1 ]
Corcia, P. [2 ,3 ]
Vourc'h, P. [2 ,4 ]
Dupuis, L. [1 ]
机构
[1] Univ Strasbourg, Inserm, UMR S1329, Ctr Rech Biomd Strasbourg, Strasbourg, France
[2] Univ Tours, UMR iBrain 1253, Inserm, Tours, France
[3] CHU Bretonneau, Ctr Constitut Coordinat SLA, 2 Blvd Tonnelle, F-37044 Tours 1, France
[4] CHU Tours, Serv Biochim & Biol Mol, Tours, France
关键词
Amyotrophic lateral sclerosis; C9ORF72; Phenotype; Pathophysiology; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; RNA FOCI; GGGGCC REPEAT; ANTISENSE TRANSCRIPTS; RAN TRANSLATION; CPG-ISLAND; PROTEINS; DISEASE; GENE;
D O I
10.1016/j.neurol.2024.03.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The major gene underlying monogenic forms of amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD) is C9ORF72. The causative mutation in C9ORF72 is an abnormal hexanucleotide (G4C2) repeat expansion (HRE) located in the first intron of the gene. The aim of this review is to propose a comprehensive update on recent developments on clinical, biological and therapeutics aspects related to C9ORF72 in order to highlight the current understanding of genotype -phenotype correlations, and also on biological machinery leading to neuronal death. We will particularly focus on the broad phenotypic presentation of C9ORF72-related diseases, that goes well beyond the classical phenotypes observed in ALS and FTD patients. Last, we will comment the possible therapeutical hopes for patients carrying a C9ORF72 HRE. # 2024 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:417 / 428
页数:12
相关论文
共 50 条
  • [21] Differential Effect of the C9ORF72 Hexanucleotide Repeat on Brain Morphology in bvFTD and FTD-ALS
    Yokoyama, Jennifer
    Takada, Leonel
    Sha, Sharon
    Karydas, Anna
    Khan, Baber
    Fong, Jamie
    DeJesus-Hernandez, Mariely
    Rutherford, Nicola
    Baker, Matthew
    Rademakers, Rosa
    Coppola, Giovanni
    Seeley, William
    Boxer, Adam
    Miller, Bruce
    Rankin, Katherine
    NEUROLOGY, 2012, 78
  • [22] Differential Effect of the C9ORF72 Hexanucleotide Repeat on Brain Morphology in bvFTD and FTD-ALS
    Yokoyama, Jennifer
    Takada, Leonel
    Sha, Sharon
    Karydas, Anna
    Khan, Baber
    Fong, Jamie
    DeJesus-Hernandez, Mariely
    Rutherford, Nicola
    Baker, Matthew
    Rademakers, Rosa
    Coppola, Giovanni
    Seeley, William
    Boxer, Adam
    Miller, Bruce
    Rankin, Katherine
    NEUROLOGY, 2012, 78
  • [23] Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72
    Qiang Zhu
    Jie Jiang
    Tania F. Gendron
    Melissa McAlonis-Downes
    Lulin Jiang
    Amy Taylor
    Sandra Diaz Garcia
    Somasish Ghosh Dastidar
    Maria J. Rodriguez
    Patrick King
    Yongjie Zhang
    Albert R. La Spada
    Huaxi Xu
    Leonard Petrucelli
    John Ravits
    Sandrine Da Cruz
    Clotilde Lagier-Tourenne
    Don W. Cleveland
    Nature Neuroscience, 2020, 23 : 615 - 624
  • [24] Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72
    Zhu, Qiang
    Jiang, Jie
    Gendron, Tania F.
    McAlonis-Downes, Melissa
    Jiang, Lulin
    Taylor, Amy
    Garcia, Sandra Diaz
    Dastidar, Somasish Ghosh
    Rodriguez, Maria J.
    King, Patrick
    Zhang, Yongjie
    La Spada, Albert R.
    Xu, Huaxi
    Petrucelli, Leonard
    Ravits, John
    Da Cruz, Sandrine
    Lagier-Tourenne, Clotilde
    Cleveland, Don W.
    NATURE NEUROSCIENCE, 2020, 23 (05) : 615 - U33
  • [25] C9orf72 Hypermethylation Influences Repeat Expansion Associated Pathology in ALS/FTD
    Liu, Elaine
    Russ, Jenny
    Wu, Kathryn
    Neal, Donald
    Suh, Eunran
    McNally, Anna
    Irwin, David
    Van Deerlin, Vivianna
    Lee, Edward B.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (06): : 620 - 620
  • [26] C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia population
    Abramycheva, Natalya Y.
    Lysogorskaia, Elena V.
    Stepanova, Maria S.
    Zakharova, Maria N.
    Kovrazhkina, Elena A.
    Razinskaya, Olga D.
    Smirnov, Andrey P.
    Maltsev, Andrey V.
    Ustyugov, Alexey A.
    Kukharsky, Michail S.
    Khritankova, Inna V.
    Bachurin, Sergey O.
    Cooper-Knock, Johnathan
    Buchman, Vladimir L.
    Illarioshkin, Sergey N.
    Skvortsova, Veronika I.
    Ninkina, Natalia
    NEUROBIOLOGY OF AGING, 2015, 36 (10) : 2908.e5 - 2908.e9
  • [27] Structural and functional MRI signatures of ALS patients with C9orf72 hexanucleotide repeat expansion
    Agosta, F.
    Ferraro, P. M.
    Riva, N.
    Domi, T.
    Copetti, M.
    Lunetta, C.
    Ferrari, M.
    Comi, G.
    Carrera, P.
    Falini, A.
    Quattrini, A.
    Filippi, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 45 - 45
  • [28] Structural and Functional MRI Signatures of ALS Patients with C9ORF72 Hexanucleotide Repeat Expansion
    Ferraro, Pilar Maria
    Agosta, Federica
    Riva, Nilo
    Domi, Teuta
    Copetti, Massimiliano
    Lunetta, Christian
    Ferrari, Maurizio
    Comi, Giancarlo
    Carrera, Paola
    Falini, Andrea
    Quattrini, Angelo
    Filippi, Massimo
    NEUROLOGY, 2016, 86
  • [29] Structural and functional MRI signatures of ALS patients with C9ORF72 hexanucleotide repeat expansion
    Agosta, F.
    Ferraro, P.
    Riva, N.
    Domi, T.
    Copetti, M.
    Lunetta, C.
    Ferrari, M.
    Comi, G.
    Carrera, P.
    Falini, A.
    Quattrini, A.
    Filippi, M.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 52 : S10 - S10
  • [30] Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD
    Niblock, Michael
    Smith, Bradley N.
    Lee, Youn-Bok
    Sardone, Valentina
    Topp, Simon
    Troakes, Claire
    Al-Sarraj, Safa
    Leblond, Claire S.
    Dion, Patrick A.
    Rouleau, Guy A.
    Shaw, Christopher E.
    Gallo, Jean-Marc
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 : 18